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Early-Onset Progressive Retinal 
Atrophy Associated with an IQCB1 
Variant in African Black-Footed Cats 
(Felis nigripes)
Annie Oh1,*, Jacqueline W. Pearce1, Barbara Gandolfi1,*, Erica K. Creighton1, 
William K. Suedmeyer2,‡, Michael Selig3,‡, Ann P. Bosiack4, Leilani J. Castaner1, 
Rebecca E. H. Whiting1,5, Ellen B. Belknap6, Leslie A. Lyons1 & 99 Lives Consortium† 
African black-footed cats (Felis nigripes) are endangered wild felids. One male and full-sibling female 
African black-footed cat developed vision deficits and mydriasis as early as 3 months of age. The 
diagnosis of early-onset progressive retinal atrophy (PRA) was supported by reduced direct and 
consensual pupillary light reflexes, phenotypic presence of retinal degeneration, and a non-recordable 
electroretinogram with negligible amplitudes in both eyes. Whole genome sequencing, conducted 
on two unaffected parents and one affected offspring was compared to a variant database from 51 
domestic cats and a Pallas cat, revealed 50 candidate variants that segregated concordantly with the 
PRA phenotype. Testing in additional affected cats confirmed that cats homozygous for a 2 base pair 
(bp) deletion within IQ calmodulin-binding motif-containing protein-1 (IQCB1), the gene that encodes 
for nephrocystin-5 (NPHP5), had vision loss. The variant segregated concordantly in other related 
individuals within the pedigree supporting the identification of a recessively inherited early-onset feline 
PRA. Analysis of the black-footed cat studbook suggests additional captive cats are at risk. Genetic 
testing for IQCB1 and avoidance of matings between carriers should be added to the species survival 
plan for captive management.
Whole genome (WGS) or whole exome sequencing (WES) can identify de novo or private variants causing a 
disease, which allows clinicians to better predict individualized effective treatments1,2. Even if clinically relevant 
genetic variation remains a challenge to define, WGS/WES of small groups of related individuals, such as trios, 
parent-offspring, affected duos, have proven powerful to identify de novo or rare variants for orphan diseases in 
many species3–5. However, WGS/WES approaches are more limited if a disease is caused by a combination of 
common and or rare variants and, especially, if the variants are in non-coding, regulatory regions of a gene. Thus, 
only ~30–40% of patients may be diagnosed by WGS/WES6,7. The power of WGS/WES causal variant identifica-
tion improves when the database of genome variants is from a variety of individuals, ethnic groups (breeds) and 
racial populations and when precise clinical data is available for each individual8–10.
The state-of-the art health care provided by WGS/WES is now available for domestic cats via the 99 Lives Cat 
Genome Sequencing Initiative (http://felinegenetics.missouri.edu/99lives)11,12. However, the application of WGS 
to endangered felid species for health care management has not been attempted previously. Captive felid popula-
tions have limited numbers of founders and health problems can easily arise as a result of deleterious mutations 
carried by one or more of the founders. Although widely available for domestic animals and humans, genetic tests 
for inherited disease are not readily available for captive felids. The identification of the rare color variants for 
white lions13 and white tigers14 could be used to outbreed these cats and reduce recognized inbreeding depression, 
however, genetic testing for these variants have not been implemented into species survival plans. Accessibility of 
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genetic tests for diseases recognized and observed in zoo populations may prove to be critical for the long-term 
survival of species that are threatened with extinction and are managed in captive breeding programs.
The black-footed cat (Felis nigripes; Fnig; Burchell, 1824) (Fig. 1a) is the smallest wild cat found in Africa, 
endemic to the arid steppe and savannah habitats of the southern African subregion15. Phylogenetic studies indi-
cate that the black-footed cat is part of the domestic cat lineage along with several other wild felids, including the 
European wildcat (Felis silvestris silvestris), African wildcat (Felis silvestris lybica), Chinese desert cat (Felis bieti), 
Sand cat (Felis margarita), and Jungle cat (Felis chaus) (Fig. 1b)16–18. Unfortunately, the size of both the wild and 
captive populations (~50 individuals in zoos worldwide) are diminishing. The species is listed under Appendix 
I–threatened with extinction–by the Convention on the International Trade of Endangered Species (CITES)19, as 
“vulnerable” by the International Union for Conservation of Nature (IUCN) since 200220, and as “Endangered” by 
the United States Fish and Wildlife Service21. Black-footed cats typically have shorter life spans in captivity than 
in the wild. The majority of captive adult black-footed cat deaths occur between 2 to 5 years, whereas free-ranging 
cats have been estimated to live approximately 5 to 6 years22. Recent reports have documented that renal amy-
loidosis plays an important role in the decreased survival of captive black-footed cats23. Information concerning 
other disease processes or conditions that occur in wild or captive black-footed cats is limited. Due to their 
endangered status and their relatively small captive breeding population, the presence of genetic defects, such as 
heritable blindness, could be detrimental for the long-term sustainability of captive black-footed cat populations.
Progressive retinal atrophy (PRA) refers to inherited retinal dystrophic or degenerative disorders present in 
animals. The age of onset and rate of progression of initial photoreceptor death varies with each species and each 
type of PRA. Initially, the disease usually affects the photoreceptor layer (specifically the rods) and proceeds to 
affect all retinal layers over time leading to diffuse retinal degeneration and ultimately blindness24. Four different 
types of PRA have been described in the domestic cat (Felis catus)25–28. In Abyssinians, an autosomal domi-
nant early-onset cone-rod dystrophy (rdy) manifests from a mutation in CRX27,29–33, while autosomal recessive 
late-onset rod-cone degeneration (rdAc) results from a mutation in CEP29026,34–38. In Persians, an autosomal 
recessive early-onset rod-cone dystrophy has been described and a causal variant in AIPL1 detected28,39,40. In 
Bengal cats, an autosomal recessive PRA has been characterized25. Due to their similarity to human globe size, rel-
atively accelerated lifespan and different represented modes of inheritance for PRA, domestic cats represent a use-
ful animal model for retinal diseases in humans such as retinitis pigmentosa and Leber’s congenital amaurosis41.
The present study describes an early-onset generalized PRA diagnosed in two full-sibling African black-footed 
cats (Felis nigripes). Clinical abnormalities in affected cats were present as early as 3 months of age. This is the first 
report of ocular disease in this species. A novel cross-species approach was used for the genetic analyses to rapidly 
identify a highly associated causal variant. Variants within the 99 Lives cat genome sequence database, which 
contains whole genome sequences of 51 domestic cats at the time of the study, were compared to the variants 
identified in the black-footed cats. Variants were prioritized as specific to the Black-footed cat and segregating 
within the trio with the PRA phenotype. A DNA-based test for management of the disease within the captive 
breeding program can now be implemented.
Results
Ophthalmic examination and diagnostic results. No significant abnormal findings were observed on 
physical assessment of the male proband cat. However, both pupils were maximally dilated in well-lit conditions, 
circular in shape, and unresponsive to light (Fig. 2a). Menace responses and dazzle reflexes were absent, and sig-
nificantly reduced direct and indirect PLRs were observed bilaterally. The cat did not show appropriate tracking 
responses. Palpebral reflexes, corneal sensitivity and oculocephalic reflexes were normal. On slit-lamp biomicros-
copy, the eyelids, conjunctiva, and anterior chamber were normal. Other abnormalities noted included faint linear 
superficial dendritic corneal facets and a relucency of the embryonic lens nucleus in the left eye. Indirect oph-
thalmoscopy identified generalized tapetal hyperreflectivity and severe vascular attenuation bilaterally (Fig. 2b) 
consistent with end-stage PRA. Schirmer I tear test values (mean ± standard deviation) were 5 mm/min in both 
eyes, which are decreased compared to the normal reference range for domestic felids (14.3 ± 5.73 mm/min)42,43. 
Figure 1. Phylogeny of the Felis lineage of small cats. (a) Image of a young black-footed cat (Felis nigripes). 
Courtesy of Cleveland Metroparks Zoo, Cleveland, OH. (b) This felid phylogeny suggests that the black-footed 
cat (Felis nigripes) had a common ancestor with the domestic cat (Felis catus) approximately 3 million years ago. 
Adapted from Li et al.17.
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Bilaterally decreased Schimer I tear test values was most likely secondary to sedation44,45. Intraocular pressure 
(IOP) data (mean ± standard deviation) collected with rebound tonometry revealed 17 mmHg bilaterally, which 
was within the normal reference interval for domestic felids (22.6 ± 4.0 mmHg)46. The cornea was fluorescein 
negative in both eyes. Physical, ophthalmic, and neuro-ophthalmic examination of the female sibling was similar 
to the male proband. Schirmer I tear test values were decreased in the right (3 mm/min) and left (5 mm/min) eye, 
presumably due to the influence of general anesthesia. The IOP measured 21 mmHg and 24 mmHg in the right 
and left eye, respectively.
In both the male proband and its female full-sibling, the electroretinogram (ERG) was non-recordable with 
a “flat line” in both eyes, consistent with end-stage PRA. Specific photoreceptor function could not be evaluated 
due to the flat (non-recordable) waveform in both cats. Complete blood hematology, chemistry, and urinalysis 
were unremarkable, and plasma taurine levels were within normal reference intervals in both cats. Indirect blood 
pressure measurements obtained under general anesthesia in both cats were found to be within normal reference 
ranges for domestic felids47–49.
CEP290, CRX, and AIPL1 genetic testing. Genetic testing of the black-footed female proband and its 
two unaffected parents was performed at the commercial service at the Veterinary Genetics Laboratory (VGL) 
at the University of California–Davis. The cats were confirmed to be wild type for the variants known to cause 
PRA in Abyssinian type domestic cats, specifically the variants within CRX27 and CEP29026, and in Persian type 
domestic cats within the AIPL1 gene12.
Variant analysis. WGS was conducted on a PRA affected female offspring (247) and its obligate carrier sire 
(205) and dam (208) (Table 1, Fig. 3). Average WGS coverage for each individual was 30X. The available database 
used for variant filtering included variants from 52 individuals, 51 domestic cats and one opportunistic Pallas cat, 
each with an average 30X genome coverage. Over 22 million variants were identified when the WGS of the trio 
of cats was aligned to the available annotated cat genome reference (Felis_catus 6.2 genome assembly)50. After 
excluding variants in common between the three black-footed cats and one Pallas cat (Otocolobus manul), over 13 
million were identified. Thus, the one Pallas cat eliminated 41% of identified variants that were common between 
the two wild felid species and found in domestic cats. Over 234,000 variants segregated concordantly when con-
sidering the phenotype within the trio and uniqueness to black-footed cats. Only fifty variants had a predicted 
high impact on a protein product, including, eight predicted stop gains, 20 predicted splice donor-acceptors and 
predicted 22 frameshift variants. The prioritization of the variants by filtering and impact is presented in Table 2.
A list of over 240 genes associated with blindness is available on the RetNet database (www.RetNet.org). Of 
50 genes with high impact variants, only three genes (RASGRF1, IQCB1 and CCDC114) had been previously 
associated with blindness (Supplementary Table 1). The RASGFR1 and CCDC114 variants were associated with 
several complex clinical features including retinal atrophy, whereas the phenotype associated with the IQCB1 
variant was always PRA with extrarenal manifestations in 10–15% of cases. The high impact variant detected 
within the coding region of IQCB1 is a 2 base pair (bp) deletion in exon 13 (c.1282delCT) and was considered 
the highest priority. The identified 2 bp variant was homozygous for the deletion in the affected cat and heterozy-
gous in both phenotypically normal parental obligate carriers (Table 3). The polymorphism is predicted to cause 
a protein truncation at position 428 of the IQCB1 amino acid chain (p.L428*), truncating the last 170 amino 
acids at the C-terminal of nephrocystin-5 (NPHP5). A pedigree for all living cats (< 50) in the North American 
black-footed cat studbook, cats with available DNA samples, and related individuals is shown (Fig. 3). The iden-
tified c.1282delCT was screened via direct sequencing in 16 available samples; blind individuals (n = 2) tested 
homozygous for the mutated allele while sighted individuals (n = 13) were heterozygous (n = 5) or homozygous 
(n = 8) wild type. One sample failed to amplify.
Figure 2. Extraocular view of the affected male proband black-footed cat (Felis nigripes). (a) The image 
demonstrates marked mydriasis in ambient light. (b) Color fundus photograph from the right eye of the 
affected male proband demonstrates diffuse vascular attenuation and tapetal hyperreflectivity consistent with 
progressive retinal atrophy in cats.
www.nature.com/scientificreports/
4Scientific RepoRts | 7:43918 | DOI: 10.1038/srep43918
In addition, seven moderate impact missense variants were identified in RetNet genes that were unique to 
black-footed cats and segregated concordantly with the disease phenotypes of the WGS trio (Table 2). Those 
Animal ID Gender Date of Birth Location Phenotype Genotype
205a M 9/21/06 CMZ Normal (parent of affected) IQCB1-carrier
208a F 2/20/07 CMZ Normal (parent of affected) IQCB1-carrier
222 F 3/12/09 KCZ Normal wt
223 F 3/12/09 OKL Normal wt
228 M 2/7/10 LOU Normal (sibling of affected) IQCB1-carrier
229 M 4/13/10 KCZ Normal wt
230 M 4/13/10 KCZ Normal wt
233 F 3/16/11 KCZ Normal wt
234 F 4/11/11 SDS Normal wt
235 M 4/17/11 KCZ PRA-affected (proband) IQCB1-mutant
236 M 4/17/11 OKL Normal (sibling of affected) wt
240 M 2/3/12 OMA Normal IQCB1-carrier
247a F 4/2/12 CMZ PRA-affected IQCB1-mutant
248 F 4/2/12 CMZ Normal (sibling of affected) IQCB1-carrier
251 F 7/12/12 SCS Normal wt
258 M 8/8/14 OMA Normal IQCB1-carrier
Table 1.  Available DNA samples from the African black-footed cat captive population. Gender: M (male), 
F (female); location: Cleveland Metroparks Zoo (CMZ), Kansas City Zoo (KCZ), Louisville Zoological Garden 
(LOU), Oklahoma City Zoo (OKL), Omaha’s Henry Doorly Zoo (OMA), Riverbanks Zoo & Garden (SCS), San 
Diego Zoo Safari Park (SDS); genotype: wild type (wt), c.1282delCT variant is homozygous in IQCB1-mutant and 
heterozygous in IQCB1-carrier; awhole genome sequenced cats. Animal identification is from the black-footed 
cat North American studbook managed by the species survival plan (B. Palmer, Denver Zoo, Denver, CO).
Figure 3. Pedigree of African black-footed cats with progressive retinal atrophy. The pedigree represents all 
living cats (< 50) in the North American studbook, cats with available DNA samples, and related individuals. 
Circles represent females, squares represent males and diamond represents cats of unspecified gender. 
Open symbols indicate phenotypically wild type (normal) cats. Solid symbols indicate PRA-affected cats. 
Half-filled symbols indicate obligate carrier cats. Diagonal lines across symbols represent deceased cats. A 
solid dot above right of the symbol indicates cats that underwent ophthalmic (Schirmer tear test I, rebound 
tonometry, fluorescein stain, slip-lamp biomicroscopy, funduscopy, and ERG) and neuro-ophthalmic (direct 
and consensual pupillary light reflexes, dazzle reflex, menace response, and measurement of horizontal pupil 
diameter) examination. Open dot below left of symbol indicates the trio of cats that were whole genome 
sequenced. The arrow indicates the male proband. A solid dot below right of symbol indicates cats with available 
DNA (blood or hair) specimens (n = 16) and were genotyped. The genotype is unknown for cats not sampled. 
Genotype are presented below the cat symbols: IQCB1 deleted 2 base pairs cytosine and thymine (delCT), wild 
type (wt), IQCB1-mutant (delCT/delCT), IQCB1-carrier (wt/delCT), wild type (wt/wt). Dotted lines represent 
the lineage of black-footed cats that segregate for vision impairment and the cross over that occurred to another 
line of breeding of cats. Cross symbol (†) indicates cats with increased risk for affected or carrier status. Line 
above the symbol indicates black-footed cats that are carriers for variants for the genes CDH23- and DTHD1_44 
based on mass spectometrocopy genotyping. Since these cats never interbred with the lineage that segregates for 
the vision impairment, CDH23 and DTHD1_144 can be excluded as candidate genes for PRA in African black-
footed cats. Seven cats in the studbook are at risk for perpetuating PRA in the black-footed cat captive breeding 
program.
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seven genes were not on the same chromosome as the putative causal IQCB1. The polymorphisms within CHD23, 
CDH3, CNGB1, DTHD1 (2 variants), RBP3 and USH1C were investigated in the additional black-footed cats 
using mass spectrometry (Table 3). Five of seven variants (CHD3, CNGB1, DTHD1_942, RBP3, and USH1C) were 
excluded because the cats’ genotype was discordant with PRA phenotype, assuming a recessive mode of inher-
itance model as suggested by pedigree analysis. Specifically, these variants were either not homozygous in the 
second PRA-affected cat or homozygous in other sighted black-footed cats. The remaining two missense variants 
(CDH23 and DTHD1_144) could not be excluded based on the genotype and phenotype discordance but were 
heterozygous each in six sighted cats from the pedigree. These variants were considered less likely associated with 
the phenotype because the variant alleles in CDH23 and DTHD1_144 were detected in unrelated black-footed 
cats that have not been interbred with the lineage that segregates for vision impairment (Fig. 3). For example, a 
visually sighted cat (223) is a DTHD1_144-carrier and this cat has no relationship to the affected lineage. WGS 
also confirmed that the cats of the trio are wild type for the known mutations within AIPL1, CRX and CEP290, 
confirming the commercial service genetic testing.
Variant 
impact*
Analysis type**
Functional Class WGS trio
Species- 
Specific
Phenotype 
Segregation
RetNet 
genes
High
Stop gain 678 454 8 —
Start/Stop loss 134 330 — —
Splice donor/
acceptor 2,547 88 22 —
Exon deletion 4 1 — —
Frameshift 3,602 722 20 1
Rare amino acid — — — —
Moderate
Codon alteration 1,462 711 13 —
Missense 47,534 32,038 595 7
Splice branch — — — —
5′ or 3′ UTR 
Deletion — — — —
Low 89,718 59,119 859 13
Modifier 22,064,948 13,437,721 232,512 1,019
Table 2.  WGS variants identified in 30x coverage of a black footed cat PRA trio. *Impact as defined by 
http://snpeff.sourceforge.net/SnpEff_manual.html#eff. **Feline reference genome sequence (V6.2) is included in 
the analyses. Effect counts are higher than variant counts because they include the effects of each alternate allele 
on each nearby gene isoform.
Animal ID Gender Phenotype Genotype IQCB1 CHD3 CNGB1 DTHD1_942 RBP3 USH1C CDH23 DTHD1_144
247a F PRA-affected delCT/delCT GG TT GG AA TT TT CC
205a M Normal wt/delCT AG CT GC AG CT CT CA
208a F Normal wt/delCT AG CT GC AG CT CT CA
235 M PRA-affected delCT/delCT AAb CC GG AGb CT TT CC
240 M Normal wt/delCT AA CT GGb GG CT CT CA
248 F Normal wt/delCT / CC / AG TT CC /
258 M Normal wt/delCT AA TTb GC GG CC CCb AAb
236 M Normal wt/wt AA CC GC AG CT CTb CAb
230 M Normal wt/wt AA CC CC GG CC CC AA
234 F Normal wt/wt / / CC GG / / AA
251 F Normal wt/wt AA CC CC GG CC CTb AA
229 M Normal wt AA CC CC GG CT CC AA
222 F Normal wt AA CT CC GG TTb CTc AA
233 F Normal wt AA CC CC GG TTb CC CAb
223 F Normal wt AA CC GC GG CT CC CAc
Table 3.  Comparison of genotype versus phenotype between seven moderate impact missense variants. 
Gender: male (M), female (F); genotype: deleted 2 base pairs cytosine and thymine (delCT), wild type (wt), 
IQCB1-mutant (delCT/delCT), IQCB1-carrier (wt/delCT), wild type (wt/wt); nucleotides: guanine (G), adenine 
(A), thymine (T), cytosine (C); “/” no data due to sample error; awhole genome sequenced trio of cats; bmissense 
variants excluded based on genotype versus phenotype mismatch; cmissense variants excluded when compared 
to the pedigree (Fig. 3). The moderate impact variant alleles are detected in unrelated black-footed cats that 
never interbred with the line of cats with vision loss.
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Discussion
The genetics of the patient is a critical aspect of an individual’s health care for some diseases. The reduced cost of 
WGS and WES has made feasible the examination of entire genomes for individualized healthcare. Animals now 
have the same benefit since lower sequencing costs have allowed the development of DNA variant databases from 
normal control animals for comparison to individuals with diseases. The study of rare, simply inherited recessive 
diseases particularly benefit from the WGS approach. Although a large database of normal DNA variants within 
the genome of black-footed cats is not available, because these wild felids are phylogenetically closely related to 
domestic cats, the domestic cat genome variant database was used for comparison of polymorphisms to exclude 
variants in common between the species. Herein is the first cross-species comparison of WGS data to support the 
captive management of an endangered species.
Vision loss is a significant concern in the vulnerable African black-footed cat as poor eyesight could result 
in a poor quality of life and failure to thrive for individuals, impacting healthy captive breeding practices for the 
species as a whole. Clinical examination of the affected male proband and female sibling cat revealed findings 
consistent with PRA. The ERG confirmed that both cats retained minimal or no retinal function, consistent with 
end-stage PRA. Clinical abnormalities in affected cats were present as early as 3 months of age and rapidly pro-
gressed to end-stage PRA, supporting an early-onset retinal disorder affecting both rod and cone photoreceptors. 
The male proband and female cat are full-siblings, but from different litters. Pedigree analysis supported an auto-
somal recessive mode of inheritance since visually normal parents produced both affected (n = 2) and unaffected 
kittens (n = 3), the parents of affected kittens had consanguinity and the affected kittens were either male (n = 3) 
and female (n = 2) (Fig. 3).
Results of ophthalmic examination and testing, pedigree analysis, and lack of evidence for nutritional, toxic, 
and hypertensive etiology for the retinal degeneration in the affected African black-footed cats strongly suggested 
a genetic basis for early-onset PRA. The male proband and female sibling cat were identified at 7 and 3 months of 
age, respectively, however initial signs of compromised photoreceptor integrity and function may have occurred 
at an earlier time point. The phenotype and electrodiagnostic findings in PRA-affected black-footed cats are 
chronologically most consistent with early-onset PRAs in Persians and Bengals, and inconsistent with autoso-
mal dominant early-onset PRA of CRX (rdy) and autosomal recessive late-onset PRA of CEP290 (rdAc)-mutant 
Abyssinians. Although the presence of a domestic cat variant for vision loss would be highly unlikely in these 
black-footed cats, genetic testing for cat PRAs is rapid and low cost. Genotyping excluded the Persian autosomal 
recessive early-onset AIPL1 variant as well as Abyssinian rdAc and rdy PRA variants. The WGS would allow more 
exhaustive consideration of these same genes for a species-specific variant.
To identify the causal gene, WGS of a trio of cats, comprising two normal obligate carrier parents, and one 
affected offspring, was conducted. This study of the single black-footed cat was assisted by comparison variants 
from the closely related domestic cat database, which included variants from 51 domestic cats and one Pallas cat 
(Otocolobus manul) at the time of the study. The Pallas cat was an opportunistic inclusion in the 99 Lives dataset, 
included as part of a separate study focusing on polycystic kidney disease. The Pallas cat is the next nearest feline 
lineage and did support the filtering of shared wild felid variants and shared variants with domestics that would 
not be causal. Forty-one percent of variants were eliminated by the cross-species comparison. One of the fifty 
high impact variants resided in a gene known to cause retinal degeneration (IQCB1) and listed on RetNet. A 
2 bp deletion within the coding region of the black-footed cats IQCB1 was detected and segregated concordantly 
with the disease phenotype (Fig. 3). The mutation is predicted to cause a protein truncation at position 428 of 
the amino acid chain (p.L428*), deleting an IQ calmodulin-binding protein domain and the complete protein 
C-terminal51. Seven moderate impact missense variants were also detected in RetNet genes that were unique to 
the three sequenced black-footed cats and segregated with the disease. Mismatch genotype and phenotype in 
addition to the probability of an unrelated cat being affected excluded five of the missense variants as potential 
candidate genes. Additionally, the remaining two variants were most likely not associated with the retinal degen-
eration since they were present in individuals unrelated to the affected cats. Although more likely not associated, 
the variants within CDH23 and DTHD1_144 will be tested along with the IQCB1 2 bp deletion in all samples that 
will be received in the future, until when excluded or confirmed by the phenotype.
Variants in IQCB1 (IQ calmodulin-binding motif-containing protein-1) are known to historically cause 
Senior-Loken syndrome (SLSN) in humans, a rare autosomal recessive disease characterized by both 
nephronophthisis (NPHP) and retinal degeneration51,52. All affected human patients with SLSN exhibit Leber 
congenital amauorsis (LCA). Leber congenital amauorsis is generally inherited in an autosomal recessive manner 
and associated with over 21 gene variants in animals and humans related to retinal function, including RPE65, 
CRX, CEP290, AIPL1, and IQCB153. The IQCB1 gene encodes nephrocystin-5 (NPHP5), one of thirteen ciliary 
proteins collectively known as nephronophthisis (NPHP) proteins54. The NPHP5 protein is present in the pho-
toreceptor connecting cilium, a zone that connects the photoreceptor cell body to the outer segments, where 
IQCB1 Interacts with CEP29051,55. The ciliary protein contains two calmodulin binding sites and co-localizes with 
nephrocystin-1, nephrocystin-451. The NPHP5 protein also interacts with nephrocystin-655 and retinal ciliopathy 
gene retinitis pigmentosa GTPase regulator (RPGR)51. Premature terminating mutations in NPHP5 lead to a 
truncated protein, which disrupts peptide transportation, compromising the structural and functional integrity 
of the photoreceptor, leading to cone and rod death and subsequent retinal degeneration51,55. Variants in NPHP 
proteins also cause a broad-spectrum of autosomal recessive kidney diseases that are the most frequent genetic 
cause of end-stage kidney disease in children and young adults56. Extra-renal manifestations occur in 10–15% 
of cases and retinal degeneration are the most common abnormality. Thus, kidney function of PRA-affected 
black-footed cats should be monitored.
IQCB1 variants have not been recognized in the domestic cat but an insertional mutation in NPHP5 (IQCB1) 
has been recently documented in American Pit Bull Terrier dogs with early-onset recessively inherited cone-rod 
dystrophy (crd2)57,58. In mutant dogs, the resulting ciliopathy causes early loss of rod photoreceptors and relative 
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retention of central retinal cone photoreceptors that lack function58. In the affected dogs, non-ophthalmic prob-
lems were neither observed nor reported. Similarly, a variant in NPHP4 is associated with recessive cone-rod dys-
trophy in Standard Wire-haired Dachshunds. No kidney involvement has been reported in affected dachshunds59.
The pedigree reveals three unique lineages in the African black-footed cat captive population (Fig. 3). The 
IQCB1-mutant gene was isolated within one lineage, but has crossed to another lineage with a recent breeding 
of cats. Ideally, the IQCB1 variant should be eliminated within the breeding population of captive black-footed 
cats. This would require all living cats (< 50) to be genotyped. Specifically cats with an increased risk for affected 
or carrier status based on the pedigree analysis and known genotypes (Fig. 3; 209, 260, 261, 262, 264, 265, and 
266). IQCB1-carriers (or CDH23 and DTHD1 carriers) would need to be mated with wild type cats. If significant 
population changes occurred in African black-footed cats that necessitated breeding of IQCB1-mutant cats from 
a conservation standpoint, they should be bred to wild type individuals to maintain maximum genetic diversity 
within this species. Additionally, the black-footed cats related to the founder cats of the PRA lineage could be 
genotyped to prevent further influx of the variant into captive breeding programs worldwide.
This is the first report of early-onset recessively inherited PRA in the African black-footed cat. Genetic analysis 
revealed the etiology to likely be a frameshift mutation in the IQCB1 gene, or a missense mutation within CDH23 
or DTHD1. IQCB1 represents the most likely variant associated with the phenotype, and the identified poly-
morphism is predicted to code for a truncated NPHP5 protein in the connecting cilium which is present in both 
rod and cone photoreceptors. Genetic testing all the candidate variants in more affected and sighted individuals 
will help confirm the causal variant associated with the PRA. The identification of the putative causal gene pro-
vides a DNA-based test for appropriate captive breeding practices and conservation of this vulnerable wild felid. 
Moreover, the WGS variant database comprised of 51 domestic cats and one Pallas cat at the time of the study has 
proven useful for cross-species comparisons for species that have recent common ancestors.
Methods
Ethical statement. All procedures used to evaluate the animals’ health were performed during the animals’ 
routine health screening at each participating zoo. Direct ophthalmoscopy and phlebotomy via jugular venipunc-
ture were performed as part of the complete physical exam on each individual. The main purpose of the blood 
specimen collection was to evaluate overall systemic health, and surplus EDTA anti-coagulated whole blood was 
submitted for genetic analyses. This study was completed in strict accordance with the recommendations from 
the Kansas City Zoo and Cleveland Metroparks Zoo Scientific Committees. Experimental protocols and applica-
tions for use of biomaterials were approved by the Kansas City, Cleveland Metroparks and Omaha’s Henry Doorly 
Zoo Research Review Committees. Examinations, blood or hair specimen collection, and advanced diagnostics 
were performed under sedation or general anesthesia. Samples were received for the genetic analyses under the 
University of Missouri Institutional Animal Care and Use Committee protocol 8313. Blood or hair samples sub-
mitted by other participating zoological parks were collected opportunistically during the cat’s animal health 
exam and were submitted for diagnostic purposes.
Animals and Clinical descriptions. The 7 month-old neutered male proband African black-footed cat 
from the Kansas City Zoo presented to the University of Missouri, College of Veterinary Medicine (MU CVM), 
Columbia, MO for suspected blindness, dilated pupils, absent dazzle reflex in both eyes, and inappropriate track-
ing of moving objects during quarantine examination. Mild horizontal nystagmus was also present in the right 
eye. Before presentation, the cat had been screened and treated for parasites, vaccinated for feline viral rhinotra-
cheitis, calicivirus, and panleukopenia (FVRCP) (Boehringer Ingelheim, St. Joseph, MO) in addition to Purevax 
Ferret Distemper (Merial Inc., Athens, GA) and was considered otherwise healthy. The cat was not receiving any 
medications and had never been administered fluoroquinolones. Daily diet provided once a day included Evo 
turkey and chicken formula (15 grams), Nebraska Canine Premium (40 grams) and a small mouse.
From a different litter, the 3 month-old intact female sibling African black-footed cat from the Cleveland 
Metroparks Zoo presented to the Metropolitan Veterinary Hospital, Akron, OH for fixed and dilated pupils and 
vision deficits bilaterally. The female sibling had a history of poor weight gain that resolved with treatment and 
increased caloric intake. On presentation, the cat had received its first vaccination for feline viral rhinotracheitis, 
calicivirus, panleukopenia, and chlamydia (FVRCP-C) (Boehringer Ingelheim, St. Joseph, MO), was not on any 
medications, and had never been administered fluroquinolone antibiotics. Daily diet included Nebraska Brand 
Premium Feline Diet (75 grams) and a mouse (25 grams). Both cats were housed indoors in an approximately 
10 × 10 foot enclosure under a 12 hour light - dark cycle.
Ophthalmic examination. Both affected African black-footed cats underwent complete physical, ophthal-
mic and neuro-ophthalmic examinations. Assessment of the male proband cat was completed under sedation and 
physical restraint by a board-certified veterinary ophthalmologist (JWP) and board-certified zoo veterinarian 
(WKS) at the MU CVM. Sedation was achieved with an intramuscular injection of ketamine (Pfizer, New York, 
NY, USA; 7 mg) and dexmedetomidine (Pfizer, New York, NY, USA; 0.55 mg), and 100% oxygen was provided 
via mask. A 24-gauge catheter was placed in the saphenous vein and Lactate Ringer’s Solution (LRS) was admin-
istered at a rate of 10 ml/kg/hour. The animals’ vital signs (heart rate, respiratory rate, and temperature) were 
evaluated every 5 minutes. Following the procedure, the sedation was reversed with an intramuscular injection of 
atipamazole (Pfizer, New York, NY, USA; 0.55 mg). Evaluation of the female sibling was performed under general 
anesthesia by a board-certified veterinary ophthalmologist (EBB) and zoo veterinarian (MS) at the Metropolitan 
Veterinary Hospital, Akron, OH. Anesthesia was ‘chamber induced’ to effect and maintained with sevoflurane 
delivered in 100% oxygen via an endotracheal tube.
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Ophthalmic diagnostics included Schirmer tear test I (Schirmer Tear Test, Schering-Plough Animal Health, 
Union, NJ, USA), rebound tonometry (TonoVet® ; Icare, Espoo, Finland) and fluorescein stain (Flu-Glo® 
Fluorescein sodium 1 mg stain; Akorn Inc., Buffalo Grove, IL, USA). Neuro-ophthalmic examinations included 
evaluation of direct and consensual pupillary light reflexes (PLRs) using a 3.5 V Finnoff transilluminator (Welch 
Allyn, Skaneateles Falls, NY, USA), assessment of dazzle reflex using white light directly from the fiberoptic cable 
of a slit lamp biomicroscope (SL-2; Kowa Optimed Inc, Torrance, CA, USA), behavioral testing of vision using 
menace response, and measurement of horizontal pupil diameter with Jameson caliper. Diffuse and focal illumi-
nation with a portable hand-held slit-lamp biomicroscope (SL-14; Kowa Col Ltd., Tokyo, Japan) was utilized to 
examine the anterior segment of both animals. Indirect ophthalmoscopy was performed with a wireless binocular 
indirect headset (12,500; Welch Allyn Inc., Skaneateles Falls, NY, USA) and a condensing lens (Pan Retinal 30D; 
Volk Optical Inc., Mentor, OH, USA). Mydriasis was not induced pharmacologically for examination of the fun-
dus due to marked pupillary dilation present in both patients. The fundus of the male proband was photographed 
with a NIDEK NM-100 digital fundus camera (NIDEK CO. LTD., Aichi, Japan).
Additional diagnostic procedures. A complete blood hematology, chemistry panel and urinalysis were 
completed in both affected African black-footed cats. Plasma taurine levels were also determined. Both affected 
cats completed electroretinography examinations (ERG) at their respective clinics. The ERG was completed in 
both cats under general anesthesia based on previous studies60. Both cats were dark adapted for at least 20 minutes 
prior to recording. Briefly, the ERG was performed utilizing a monopolar electrode-contact lens (ERG-jet; Nicolet 
Instruments, Madison, WI, USA) applied to the cornea with hypromellose 2.5% gel as a coupling agent (Gonak; 
Akorn, Inc., Buffalo Grove, IL, USA) and male subdermal platinum needle electrodes (FD-E2–24; Astro-Medical, 
Inc. Warwick, RI, USA). The ERG for the male proband was performed with a Handheld Multispecies ERG 
(HMsERG) (HMsERG Model 1000; RetVetCorp, Columbia, MO, USA) using the Quick Ret Check Protocol. The 
ERG for the female sibling was performed with a Retinographics unit (Retinographics Inc., Norwalk, CT). For 
both cats, mixed rod and cone responses were assessed with a standard flash intensity of 3 cd.s/m2. Mixed rod and 
cone responses of the male cat were also evaluated with a high intensity flash (10 cd.s/m2). Indirect blood pressure 
measurement was performed under general anesthesia in both cats.
All additional cats in the study with available DNA samples (n = 14), including the parents of the siblings, 
were reported to behave in a visually appropriate manner and failed to demonstrate any visual deficits.
Genetic analyses. African black-footed cats (n = 16; eight males and eight female cats) from the captive 
populations at seven zoological parks were evaluated (Table 1). An aliquot of the DNA was submitted for com-
mercial genotyping to the Veterinary Genetics Laboratory at the University of California, Davis, to screen for 
the three known variants associated with PRA in cats: AIPL1, CRX and CEP290. DNA for WGS was isolated 
by organic extraction from EDTA anti-coagulated whole blood collected from a trio of African black-footed 
cats, including the obligate carrier sire (205) and dam (208), and affected female offspring (247) (Table 1). The 
WGS libraries and sequencing were performed at the University of Missouri DNA Core on an Illumina HiSeq 
2000 as previously described11. Cat WGS filtering and genome-wide variant calling were performed as previously 
described by Maverix Biomics, Inc. (San Mateo, CA)11 and as part of the 99 Lives whole genome sequencing 
initiative (http://felinegenetics.missouri.edu/99lives). Briefly, the WGS from the trio was aligned to the available 
annotated cat genome reference (Felis_catus 6.2 genome assembly) to identify variants50. All variants detected 
in the black-footed cat trio were filtered based on the known individuals’ phenotype and using the available 
variant dataset comprised of 52 whole genome sequenced cats, including one Pallas cat and 51 domestic cats. 
Variants were filtered as follows (1) considering variants only segregating in the black-footed cat trio, (2) exclud-
ing variants in common with black-footed cat and Pallas cat, (3) excluding variants shared in domestic and 
black-footed cats, (4) variants in concordant segregation with the autosomal recessive disease phenotype within 
the black-footed cat trio, and, (5) identifying variants in known retinal genes. A list of genes causing retinal dis-
eases from the RetNet database (www.RetNet.org) was obtained and variants were visually investigated within 
those genes. Variants were prioritized by their effect on the protein using SNPeff (http://snpeff.sourceforge.net/
SnpEff_manual.html#eff).
IQ calmodulin-binding motif-containing protein-1 (IQCB1) variant genotyping. A direct 
sequencing assay was performed to screen a possible causative variant within the candidate gene IQCB1 in all avail-
able black-footed cats with known phenotype (n = 16, Table 1). Two primers were designed on the variant flanking 
regions (IQCB1-FCCTCTCCTCATACACACTCAGAGTTA, IQCB1-R CGGTGTCTTTGGAGATAGTCATC) 
and PCR was performed at 58 °C annealing temperature. Cycles, reagents final concentrations, PCR purification 
and direct Sanger sequencing were performed as previously described61. Sanger sequencing was completed at the 
DNA Core at the University of Missouri on an ABI 3730 DNA Analyzer (Applied Biosystems, Foster City, CA).
Mass spectroscopy variant genotyping. Candidate variants associated with a missense change in a 
RetNet gene were selected for genotyping. Assays were designed using the MassARRAY Assay Design included in 
the package Typer 4.0 (Agena Bioscience, San Diego, CA) according to manufacturer’s instructions. A multiplex 
consisting of seven SNPs in six different genes (CHD3, CNGB1, DTHD1, RBP3, USH1C and CDH23) was selected 
(Supplementary Table 1), genotyping was performed on all available samples using the Agena Biosciences iPLEX 
Gold Genotyping reagent set and products were typed with the MassARRAY System with Nanodispenser RS1000 
(Agena Bioscience).
www.nature.com/scientificreports/
9Scientific RepoRts | 7:43918 | DOI: 10.1038/srep43918
Assay performance and validation. All data was inspected with Typer Analyzer to assess assay quality 
and assays with weak or ambiguous signals were discarded. Next, the Autocluster algorithm of Typer Analyzer 
was selected and only assays with “Conservative” or “Moderate” calls were considered. Moreover, the three WGS 
black-footed cats functioned as positive controls for assay validation.
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